ea0063p483 | Calcium and Bone 2 | ECE2019
Askitis Dimitrios
, Karanikas Michail
, Michalopoulos Nikolaos
, Strataki Aphroditi
, Zissimopoulos Athanasios
Introduction: Primary hyperparathyroidism comprises one of the major causes of hypercalcaemia and is mostly due to solitary parathyroid adenoma. Denosumab is a novel antiresorptive agent for osteoporosis treatment and has been associated with a compensatory increase in PTH levels during the first months after injection, a fact that may interfere in the diagnostic procedures when dealing with concomitant small parathyroid adenomas without standard scintigraphic pattern.<p c...